Johnson & Johnson, AstraZeneca to Resume Coronavirus Vaccine Clinical Trials in US

American pharmaceutical6

American pharmaceutical company Johnson & Johnson announced halting its COVID-19 vaccine clinical trials on 12 October after one of its program participants exhibited an “unexplained illness”. The British company paused worldwide trials on 6 September after it was revealed that neurological illnesses were being reported among participants.

US medical company Johnson & Johnson is preparing to resume clinical trials of its coronavirus vaccine after testing of the new drug was halted on 12 October due to an “unexplained illness” in one of the study participants, the company announced on Friday.

Continue reading https://sptnkne.ws/EdUd